Funder
Wu Jieping Medical Foundation Special Fund For Clinical Research
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference43 articles.
1. Bray, F., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424.
2. Witayateeraporn, W., et al. (2020). Alpha7-Nicotinic acetylcholine receptor antagonist QND7 suppresses non-small cell lung cancer cell proliferation and migration via inhibition of Akt/mTOR signaling. Biochemical and Biophysical Research Communications, 521(4), 977–983.
3. Postmus, P. E., et al. (2017). Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 28(4), iv1–iv21.
4. Crino, L., & Cappuzzo, F. (2002). Present and future treatment of advanced non-small cell lung cancer. Seminars in Oncology, 29(3 Suppl 9), 9–16.
5. Ma, P. C. (2012). Personalized targeted therapy in advanced non-small cell lung cancer. Cleveland Clinic Journal of Medicine, 79, eS56-60.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献